Friday, 3 September 2021
DRL, Natco rise on nod for Revlimid copy
Shares of Dr. Reddy’s Laboratories and Natco Pharma gained almost 2% and more than 4%, respectively on Thursday after the drugmakers announced the unv
from The Hindu - Business
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment